Riptide Ventures — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

Capsulomicscapsulomics.com in 𝕏Mar 2023 · $3M

Capsulomics offers Esopredict, a DNA methylation-based risk-stratification test that predicts progression from Barrett's esophagus to high-grade dysplasia or esophageal adenocarcinoma for gastroenterologists and pathologists.

AI & Machine LearningBiotechDigital HealthMedical DevicesHalethorpe, US

Daniel Lunz(Executive Officer, Director)inWilliam Stevens(Executive Officer)inStephen Meltzer(Director)

BoardJohn Neiderhuber(Director)

Co-investorsEarly Light Ventures Gaingels Maryland TEDCO TEDCO

Caretaker Medicalcaretakermedical.net in 𝕏Feb 2023

Caretaker Medical develops wireless medical devices for non-invasive continuous hemodynamic monitoring using patented Pulse Decomposition Analysis technology.

Digital HealthHardwareHealthtechMedical DevicesCharlottesville, US

Martin Baruch(Executive Officer, Director)inJeff Pompeo(Executive Officer, Director, Promoter)inTodd Hochrein(Executive Officer, Director)in

BoardMark Rausch(Director)inPaul Jansen(Director)Rolf Hueppi(Director)

PartnerMike Leffer· solo GP

Co-investorsEarly Light Ventures IrishAngels Ming capital

Previseprevise.co in 𝕏Mar 2023 · $3M

Previse offers a data health monitor and financial technology tools that harmonize fragmented financial data across multiple systems, using no-code ERP connectors, payment automation, and configurable workflows and analytics.

AI & Machine LearningData & InfrastructureFintechLondon, GB

Philipp Schoenbucher(Founder)in

Co-investorsAugmentum Fintech Founders Factory Reefknot Investments Salica Investments Bessemer Venture Partners Gaingels +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.